PUT - SPRINTER OPEN END - STRYKER CORP. Stock

Certificat

DE000VD28GZ0

Real-time Boerse Frankfurt Warrants 04:23:38 2024-07-04 EDT
2.41 EUR -4.74% Intraday chart for PUT - SPRINTER OPEN END - STRYKER CORP.
Current month+41.34%
1 month+31.09%
Date Price Change
24-07-04 2.41 -4.74%
24-07-03 2.53 +2.43%
24-07-02 2.47 +16.51%
24-07-01 2.12 +18.44%
24-06-28 1.79 -3.76%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 04:23 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD28GZ
ISINDE000VD28GZ0
Date issued 2024-04-03
Strike 358.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.84
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.36
Lowest since issue 0.48
Spread 0.19
Spread %7.28%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
332 USD
Average target price
372.7 USD
Spread / Average Target
+12.27%
Consensus